Search

everythinglearnresearchcommunity

for

Search:↓

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Finasteride works better for hair loss in patients 26 or younger.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Women with PCOS have lower amylin levels, which are not related to their body weight.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Long-term diabetes is linked to lower prostate cancer risk.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Women with PCOS have higher oxidative stress and hormone imbalances, suggesting managing oxidative stress could help.

Finasteride improves acne and hair loss in women with normal testosterone.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Androgens increase muscle mass by promoting myoblast growth through ornithine decarboxylase.

Higher insulin levels are linked to larger ovaries in women with idiopathic hirsutism.

DHT in the human prostate is produced through multiple pathways, not just from testosterone.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

Testosterone therapy helps boys with hormone deficiencies develop normal male characteristics and grow properly.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

Continued research and awareness are needed to improve treatments for androgen-dependent diseases.